<?xml version='1.0' encoding='utf-8'?>
<document id="22316009"><sentence text="P-glycoprotein-based loperamide-cyclosporine drug interaction at the rat blood-brain barrier: prediction from in vitro studies and extrapolation to humans."><entity charOffset="21-31" id="DDI-PubMed.22316009.s1.e0" text="loperamide" /><entity charOffset="32-44" id="DDI-PubMed.22316009.s1.e1" text="cyclosporine" /><pair ddi="false" e1="DDI-PubMed.22316009.s1.e0" e2="DDI-PubMed.22316009.s1.e0" /><pair ddi="false" e1="DDI-PubMed.22316009.s1.e0" e2="DDI-PubMed.22316009.s1.e1" /></sentence><sentence text="We have shown that the rat can quantitatively predict the verapamil-cyclopsorine A (CsA) drug-drug interaction (DDI) at the human blood-brain barrier (BBB)"><entity charOffset="58-82" id="DDI-PubMed.22316009.s2.e0" text="verapamil-cyclopsorine A" /></sentence><sentence text=" In addition, the potency (EC(50)) of CsA to inhibit rat BBB P-gp can be predicted from in vitro studies in MDRI-transfected cells" /><sentence text=" To assess if these excellent agreements extend to other substrates, we determined the magnitude of P-gp-based DDI at the rat BBB between loperamide (Lop) or its metabolite, N-desmethyl Lop (dLop), and escalating CsA blood concentrations"><entity charOffset="138-148" id="DDI-PubMed.22316009.s4.e0" text="loperamide" /></sentence><sentence text=" The percent increase in the brain:blood Lop concentration ratio was described by the Hill equation, E(max) = 2000%, EC(50) = 7" /><sentence text="1 μM and γ = 3" /><sentence text="7" /><sentence text=" The potency (EC(50)) of CsA to inhibit P-gp at the rat BBB was independent of the substrate used (verapamil, Lop, or dLop)" /><sentence text=" Like the verapamil-CsA DDI, the potency (EC(50)) of CsA to inhibit rat BBB P-gp could be predicted from studies in MDRI-transfected cells" /><sentence text=" When (11)C-Lop was coadministered with a 10 mg/kg iv infusion of CsA (1) yielding ~5" /><sentence text="6 uM CsA blood concentration to healthy volunteers, the brain distribution of (11)C-radioactivity was increased by 110%" /><sentence text=" (1) When corrected for diffusible Lop metabolite(s), this translates into an increase in (11)C-Lop brain distribution of 457%" /><sentence text=" Based on our rat data, we estimated a similar value at 5" /><sentence text="6 μM blood CsA concentration, 588% increase in Lop brain distribution" /><sentence text=" These data support our conclusion that the rat is a promising model to predict P-gp based DDI at the human BBB" /><sentence text="" /></document>